Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:1738-1745
Published online before print May 25, 2006, doi: 10.1161/01.ATV.0000228844.65168.d1
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
26/8/1738    most recent
01.ATV.0000228844.65168.d1v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adams, T. E.
Right arrow Articles by Huntington, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adams, T. E.
Right arrow Articles by Huntington, J. A.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:1738.)
© 2006 American Heart Association, Inc.


Brief Reviews

Thrombin-Cofactor Interactions

Structural Insights Into Regulatory Mechanisms

Ty E. Adams; James A. Huntington

From the University of Cambridge, Department of Haematology, Division of Structural Medicine, Thrombosis Research Unit, Cambridge Institute for Medical Research, UK.

Correspondence to James A. Huntington, University of Cambridge, Division of Structural Medicine, Cambridge Institute for Medical Research, Cambridge CB2 2XY, UK. E-mail jah52{at}cam.ac.uk

Precise modulation of thrombin activity throughout the hemostatic response is essential for efficient cessation of bleeding while preventing inappropriate clot growth or dissemination which causes thrombosis. Regulating thrombin activity is made difficult by its ability to diffuse from the surface on which it was generated and its ability to cleave at least 12 substrates. To overcome this challenge, thrombin recognition of substrates is largely controlled by cofactors that act by localizing thrombin to various surfaces, blocking substrate binding to critical exosites, engendering new exosites for substrate recognition and by allosterically modulating the properties of the active site of thrombin. Thrombin cofactors can be classified as either pro- or anticoagulants, depending on how substrate preference is altered. The procoagulant cofactors include glycoprotein Ib{alpha}, fibrin, and Na+, and the anticoagulants are heparin and thrombomodulin. Over the last few years, crystal structures have been reported for all of the thrombin-cofactor complexes. The purpose of this article is to summarize the features of these structures and to discuss the mechanisms and physiological relevance of cofactor binding in thrombin regulation.

Substrate recognition by thrombin is largely controlled by cofactors, and crystal structures have now been reported for all of the thrombin-cofactor complexes. The purpose of this article is to summarize the features of these structures and to discuss the mechanisms and physiological relevance of cofactor binding in thrombin regulation.


Key Words: thrombin • hemostasis • regulation • cofactor • specificity




This article has been cited by other articles:


Home page
LupusHome page
R. Urbanus, R. Derksen, and P. de Groot
Platelets and the antiphospholipid syndrome
Lupus, October 1, 2008; 17(10): 888 - 894.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
T. Myles and L. L. K. Leung
Thrombin Hydrolysis of Human Osteopontin Is Dependent on Thrombin Anion-binding Exosites
J. Biol. Chem., June 27, 2008; 283(26): 17789 - 17796.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. C. Berndt and R. K. Andrews
New Direction for WE Thrombin
Arterioscler Thromb Vasc Biol, February 1, 2008; 28(2): 205 - 207.
[Full Text] [PDF]